Atherectomy Devices Market - Global Forecast 2025-2032

Senior decision-makers in the atherectomy devices market face a landscape shaped by continual regulatory changes and rapid technology innovation. Successful leadership relies on strategic agility to align organizational priorities with evolving vascular intervention standards and ensure consistent operational performance.

Market Snapshot: Atherectomy Devices Market Size and Growth Dynamics

In 2024, the global atherectomy devices market was valued at USD 1.03 billion. By 2025, the market is expected to reach USD 1.12 billion, with a compound annual growth rate (CAGR) of 8.69% projected through 2032. Growth in this sector is driven by persistent demand for less invasive vascular procedures, supported by advancements in device design that promote efficiency and collaboration within clinical care networks. Innovation is enhancing the reimbursement environment, and regional development depends on differences in economic conditions as well as technology adoption rates. These factors directly shape procurement strategies and supply chain management across key healthcare markets.

Scope & Segmentation: Atherectomy Devices Market

• Device Types: Directional, laser, orbital, and rotational atherectomy devices are engineered to address specific lesions and diverse arterial anatomies, providing clinicians with options for a broad range of intervention requirements.
• Applications: Suitable for both coronary and peripheral procedures, these devices enable treatment spanning carotid to lower limb arterial diseases, equipping health systems to deliver comprehensive vascular care.
• End Users: Hospitals, ambulatory surgical centers, and outpatient vascular labs adopt advanced intervention devices to enhance cardiovascular service delivery and improve patient management workflows.
• Mode Types: Atherectomy devices operate in both continuous and intermittent modes, offering procedural flexibility so clinical teams can adapt to cases from routine to complex.
• Regions Covered: The Americas, Europe, Middle East, Africa, and Asia-Pacific each demonstrate distinct regulatory frameworks and healthcare infrastructures, which inform their regional strategies for technology adoption and device procurement.
• Key Companies Profiled: Key industry participants include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., AngioDynamics, Inc., Terumo Corporation, Becton, Dickinson and Company, OrbusNeich Medical Company Limited, and ConMed Corporation.

Atherectomy Devices Market: Key Takeaways for Senior Decision-Makers

• Adoption of advanced imaging within atherectomy procedures increases procedural precision, which supports improved clinical results and facilitates less invasive interventions.
• Expansion of automated manufacturing and stronger supply chain networks enables providers to optimize inventory levels and maintain consistency during operational challenges.
• Prioritizing comprehensive clinical training for multidisciplinary teams reinforces best practices, which standardizes care protocols and enhances procedural outcomes across different facility types.
• Integration of digital health tools and analytics supports ongoing measurement of organizational performance, supplying actionable insights that help synchronize clinical and operational strategies.
• Continuous regulatory monitoring allows organizations to quickly adapt strategies in response to new reimbursement models and evolving market access policies across global regions.

Tariff Impact: Navigating Cost Pressures and Sourcing Strategies

Recent updates to U.S. tariffs have increased the expense of critical atherectomy device components, such as optical fibers and catheters. Leading organizations are responding by expanding domestic manufacturing and strengthening local supplier partnerships. Healthcare systems are implementing agile sourcing and procurement models to counter price fluctuations, uphold reliable device availability, and reduce exposure to regulatory risk.

Methodology & Data Sources

This analysis uses comprehensive secondary research alongside detailed expert interviews and supply chain assessments. Data points are triangulated to ensure high accuracy, delivering strategic recommendations that are practical and relevant for leadership decision-making in the atherectomy devices market.

Why This Atherectomy Devices Market Report Matters

• Delivers timely insights on sector trends, drivers of innovation, and regional segment opportunities to inform improved market positioning.
• Prepares organizations for regulatory and operational shifts by outlining frameworks for efficient procurement and scalable growth approaches.
• Guides leadership teams in building agility and sustaining reliable performance as clinical standards advance in global vascular care practice.

Conclusion

This report equips senior decision-makers with actionable market intelligence to steer innovation and reinforce operational resilience within the evolving landscape of vascular interventions.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.